Synapse - Genitourinary Oncology Service

Results (5696)

A composite score of 5 circulating biomarkers predicts benefit from everolimus: Results from 442 patients (pts) randomized on RECORD-3

Meeting Abstract

Voss, M. H.; Chen, D.; Marker, M.; Hsieh, J.; Knox, J. J.; Anak, O.; Motzer, R. J.
BJU International (2014)

Fulltext@MSK | Save

Patients with PD-L1 expression by IHC 1/2/3 demonstrated evidence of increased activity. Durable responses were observed in mRCC patients, warranting further study Randomized, dose-ranging phase II trial of nivolumab for metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Motzer, R.; Rini, B.; McDermott, D.; Redman, B.; Kuzel, T.; Harrison, M.; Vaishampayan, U.; Drabkin, H.; George, S.; Logan, T.; more...
BJU International (2014)

Fulltext@MSK | Save

A phase 3, randomized, open-label study of nivolumab combined with ipilimumab versus sunitinib monotherapy in subjects with previously untreated metastatic renal cell carcinoma

Meeting Abstract

Hammers, H.; Sternberg, C.; McDermott, D. F.; Larkin, J.; Ravaud, A.; Rini, B.; Sharma, P.; Bhagavatheeswaran, P.; Gagnier, P.; Motzer, R.
BJU International (2014)

Fulltext@MSK | Save

Phase I study of nivolumab in combination with ipilimumab (IPI) in metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Hammers, H.; Plimack, E. R.; Infante, J. R.; Ernstoff, M. S.; Rini, B.; McDermott, D. F.; Razak, A.; Pal, S. K.; Voss, M. H.; Sharma, P.; more...
BJU International (2014)

Fulltext@MSK | Save

Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Amin, A.; Plimack, E. R.; Infante, J. R.; Ernstoff, M. S.; Rini, B.; McDermott, D. F.; Knox, J.; Pal, S. K.; Voss, M. H.; Sharma, P.; more...
BJU International (2014)

Fulltext@MSK | Save

Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: Results of a phase II nonrandomized expansion study

Journal Article

Smith, M. R.; Sweeney, C. J.; Corn, P. G.; Rathkopf, D. E.; Smith, D. C.; Hussain, M.; George, D. J.; Higano, C. S.; Harzstark, A. L.; Sartor, A. O.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

From molecular understanding to clinical advances

Journal Article

Lee, C. H.; Motzer, R. J.
Nature Reviews Urology (2014)

Fulltext@MSK | Save

Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer

Journal Article

Nazarian, A.; Lawlor, K.; Yi, S. S.; Philip, J.; Ghosh, M.; Yaneva, M.; Villanueva, J.; Saghatelian, A.; Assel, M.; Vickers, A. J.; more...
Molecular & Cellular Proteomics (2014)

Fulltext@MSK | Save

Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1H magnetic resonance spectroscopic imaging

Journal Article

Matulewicz, L.; Jansen, J. F. A.; Bokacheva, L.; Vargas, H. A.; Akin, O.; Fine, S. W.; Shukla-Dave, A.; Eastham, J. A.; Hricak, H.; Koutcher, J. A.; more...
Journal of Magnetic Resonance Imaging (2014)

Fulltext@MSK | Save

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors

Journal Article

Lee, W.; Teckie, S.; Wiesner, T.; Ran, L.; Prieto Granada, C. N.; Lin, M.; Zhu, S.; Cao, Z.; Liang, Y.; Sboner, A.; more...
Nature Genetics (2014)

Fulltext@MSK | Save